Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models

SIMPLE SUMMARY: The objective of this study is to identify potential proteomic biomarkers in triple negative breast cancer (TNBC) that associate with response to PI3K inhibitors which are in clinical trials. We tested a panel of TNBC patient-derived xenograft (PDX) models for their tumor growth resp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Guo, Zhanfang, Primeau, Tina, Luo, Jingqin, Zhang, Cynthia, Sun, Hua, Hoog, Jeremy, Gao, Feng, Huang, Shixia, Edwards, Dean P., Davies, Sherri R., Aft, Rebecca, Ding, Li, Ellis, Matthew J., Li, Shunqiang, Ma, Cynthia X.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7765949/
https://ncbi.nlm.nih.gov/pubmed/33371187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123857
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados